Treatment of Disseminated High Grade Lymphoma
NCT00536393 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2007-11-01
Summary
Interest of the use of pegylated liposomal doxorubicin (caélyx)
Conditions
Interventions
- DRUG
-
Doxorubicin
- DRUG
-
Doxorubicin pegylated
Sponsors & Collaborators
-
French Innovative Leukemia Organisation
lead OTHER
Principal Investigators
-
Guillaume CARTRON, Dr · French Innovative Leukemia Organisation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 60 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-10-31
- Completion
- 2004-10-31
Countries
- France
Study Locations
More Related Trials
-
Treatment of Localized Low Grade Lymphomas
NCT00536458 ·Status: COMPLETED ·Phase: PHASE3
-
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
NCT01856192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
NCT00670358 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lenalidomide and R-CHOP in B-cell Lymphoma
NCT00901615 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients
NCT00120198 ·Status: TERMINATED ·Phase: PHASE2
-
Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma
NCT00169195 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma
NCT03022123 ·Status: UNKNOWN ·Phase: NA
-
Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients
NCT04164368 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
NCT06356129 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas
NCT03985696 ·Status: UNKNOWN ·Phase: NA
-
Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00244985 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
NCT01197560 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma
NCT04214626 ·Status: COMPLETED ·Phase: PHASE2
-
R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia
NCT00504491 ·Status: WITHDRAWN ·Phase: PHASE2
-
Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL
NCT04263584 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas
NCT00183976 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma
NCT02285062 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma
NCT06935136 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Lenalidomide Maintenance Post-debulking in Advanced CTCL
NCT01098656 ·Status: TERMINATED ·Phase: PHASE3
-
A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients
NCT03650933 ·Status: RECRUITING ·Phase: PHASE3
-
R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma
NCT00788606 ·Status: TERMINATED ·Phase: PHASE2
-
RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis Factor
NCT03536039 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma
NCT00435955 ·Status: UNKNOWN ·Phase: PHASE3
-
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
NCT00290667 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma
NCT00907348 ·Status: UNKNOWN ·Phase: PHASE2